United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
RTP firm to test pig kidneys in humans in groundbreaking trial
A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
United Therapeutics' president sells shares worth $3.48 million
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
Smithsonian Magazine5d
FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
Experimental transplants with organs from gene-edited pigs see major steps forward
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
HealthDay on MSN5d
FDA Approves Clinical Trials for Pig Kidney Transplants in Humans
HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...
NH man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...
Morningstar2d
United Therapeutics Corp UTHR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...